APA、CHI和Spring Health敦促林业发展局在精神保健设备方面,为了安全和隐私,对AI进行管制。 APA, CHI, and Spring Health urge FDA to regulate AI in mental health devices for safety and privacy.

2025年10月25日,美国精神病学协会,联网健康倡议和春季健康敦促FDA在心理健康设备中制定更严格的对生成人工智能的规定. On October 25, 2025, the American Psychiatric Association, the Connected Health Initiative, and Spring Health urged the FDA to establish stronger regulations for generative AI in mental health devices. 他们呼吁进行明确的监督,以确保安全、效率、透明度和病人隐私,并列举偏见、数据滥用和不可靠的大赦国际决定等风险。 They called for clear oversight to ensure safety, efficacy, transparency, and patient privacy, citing risks like bias, data misuse, and unreliable AI decisions. 这些团体强调,随着AI工具在精神保健中日益普遍,需要适应性强、持续监测和问责。 The groups emphasized the need for adaptable, ongoing monitoring and accountability as AI tools become more common in mental health care. 他们的评论是 FDA 面临越来越大的压力的一部分，要求为人工智能驱动的健康技术制定现代、灵活的指南。 Their comments are part of growing pressure on the FDA to develop modern, flexible guidelines for AI-driven health technologies.